Physician profile
Steven Barrientos
NPI 1164959276
$748.33
in general payments reported to CMS, 2019-2025
19 companies · $33.93 in 2025
The $33.93 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.55 · 2020: $132 · 2021: $399 · 2022: $147 · 2024: $20.41 · 2025: $33.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $54.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $54.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $216.71 | 2021 | |
| Pacira Therapeutics, INC. | $80.04 | 2020-2021 | |
| Integra Lifesciences Corporation | $76.62 | 2021 | |
| Abbvie INC. | $63.30 | 2022 | |
| Radius Health, INC. | $36.49 | 2024-2025 | Tymlos |
| Trice Medical, INC. | $27.50 | 2021 | |
| Pfizer INC. | $27.35 | 2022 | |
| Lilly USA, LLC | $25.65 | 2022 | |
| Sun Pharmaceutical Industries INC. | $20.81 | 2020 | |
| Genzyme Corporation | $20.47 | 2020 | |
| Gilead Sciences, INC. | $20.17 | 2021 | |
| Ibsa Pharma INC. | $19.60 | 2021 | |
| Amgen INC. | $18.19 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $17.85 | 2025 | |
| Philips North America LLC | $17.22 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $16.96 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.55 | 2019 | |
| Astellas Pharma US INC | $14.60 | 2020 | |
| Currax Pharmaceuticals LLC | $12.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Barrientos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.